Using Proton Pump Inhibitors (PPIs) alongside warfarin – clinical considerations

17 June 2022PPIs may enhance warfarin anticoagulation. Patients on warfarin require counselling when started on a PPI and INR monitored appropriately.

Proton pump inhibitor (PPI) formulations suggested for adults with swallowing difficulties

1 July 2021A range of proton pump inhibitors are suitable for adults with swallowing difficulties.

Safety in Lactation: Drugs for disorders of gastric acid and ulceration

21 September 2020Additional information relating to breastfeeding To be used in conjunction with individual drug entries for specific information and guidance. Drugs for dyspepsia Aluminium and magnesium…

Do proton pump inhibitors reduce the clinical efficacy of clopidogrel?

25 July 2019This updated Medicines Q&A evaluates the available evidence for an interaction between clopidogrel and proton pump inhibitors Summary Clopidogrel is converted into its active metabolite…

Is there an interaction between bisphosphonates and proton pump inhibitors?

21 June 2019This updated Medicines Q&A evaluates the evidence for an interaction between bisphosphonates and proton pump inhibitors.  
Search Articles

Medicine Compliance Aid Stability

genericTeva UK Ltd

Teva UK Ltd
Capsules g/r 15mg, 30mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
Protect from light
Airtight container recommended.
6 November 2015

Zoton FasTabPfizer Ltd

Pfizer Ltd
Zoton FasTab
Tablet orodispersible 15mg, 30mg
R2 · Red 2Drug is not suitable for CAs due to theoretical reasons that cannot be mitigated.
Highly sensitive to moisture, so unsuitable for inclusion in MCA.
6 November 2015

Lactation Safety Information

Omeprazole, Pantoprazole
Likely to be degraded in infant's GI tract
No published evidence of safety
11 July 2016